IDSA GUIDELINES Bundle (free trial)

Drug-Susceptible Tuberculosis

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/770889

Contents of this Issue

Navigation

Page 7 of 23

8 Treatment Table 2. Doses a of Antituberculosis Drugs for Adults and Children b Drug Preparation Population First-line drugs Isoniazid Tablets (50 mg, 100 mg, 300 mg ); elixir (50 mg/5 mL); aqueous solution (100 mg/mL) for intravenous or intramuscular injection. Note: Pyridoxine (vitamin B6), 25–50 mg/ day, is given with INH to all persons at risk of neuropathy (eg, pregnant women; breastfeeding infants; persons with HIV; patients with diabetes, alcoholism, malnutrition, or chronic renal failure; or patients with advanced age). For patients with peripheral neuropathy, experts recommend increasing pyridoxine dose to 100 mg/d. Adults Children Rifampin Capsule (150 mg, 300 mg ) Powder may be suspended for oral administration. Aqueous solution for intravenous injection. Adults c Children Rifabutin Capsule (150 mg ) Adults d Children Rifapentine Tablet (150 mg film coated) Adults Children Pyrazinamide Tablet (500 mg scored) Adults Children Ethambutol Tablet (100 mg, 400 mg ) Adults Children f Second-line drugs Cycloserine Capsule (250 mg ) Adults g Children Ethionamide Tablet (250 mg ) Adults h Children

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Drug-Susceptible Tuberculosis